Their study, covering primary B19V infection cases from 2012 to 2024—including the 2023–2024 European outbreak—identified four distinct virological profiles based on combined B19V DNA quantification and IgM/IgG serology, aligning with the known pathophysiology and temporal sequence of infection [19]. The gene discussed is CD40LG; the disease is infection.